FDNA Expands Facial Analysis Reach to 2,000 Syndromes: New milestone in the fight against rare diseases enables earlier detection and treatment

BUSINESS WIRE – “FDNA, a Boston-based digital health company and developer of the Face2Gene suite of applications, is pleased to announce that its facial analysis technology has analyzed facial images of tens of thousands of patients for more than 2,000 different rare genetic diseases. This data is used to recognize associations between facial characteristics and these genetic diseases. This milestone marks a major achievement for a company devoted to ending the lengthy diagnostic journey that accompanies rare diseases.”